Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,103,944
+$8,012 QoQ
Shares Held
4,387
-12.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#2,447
of 4,152 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CWS Financial Advisors, LLC holds $4,559,279 across 7 Drug Manufacturers - General names. ABBV ranks #1 (24.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
4,387 | $1,103,944 | |
| 2 | JNJ |
Johnson & Johnson
|
3,919 | $995,308 | |
| 3 | LLY |
ELI LILLY & Co
|
705 | $845,598 | |
| 4 | AMGN |
Amgen Inc
|
1,490 | $539,558 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,162 | $399,487 | |
| 6 | PFE |
Pfizer Inc
|
14,856 | $357,732 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,472 | $317,652 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,103,944 | 4,387 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,095,932 | 5,039 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,142,906 | 5,002 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,154,921 | 4,988 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $986,570 | 5,315 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,252,091 | 5,976 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $988,012 | 5,560 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $952,051 | 4,821 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $826,897 | 4,821 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $814,169 | 4,471 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $843,966 | 5,446 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $792,104 | 5,314 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $636,599 | 4,725 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $936,617 | 5,877 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $881,905 | 5,457 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $843,912 | 6,288 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $911,302 | 5,950 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,079,814 | 6,661 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $881,860 | 6,513 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $626,503 | 5,562 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $590,556 | 5,457 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $582,681 | 5,438 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $492,255 | 5,620 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $621,184 | 6,327 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $421,254 | 5,529 | Shares | Sole | 2020-04-02 | |
| No filing history on record for this holder in this stock. | ||||||